CoChat

Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance

Open access
Hurst-Hess, Kelley, Rudra, Paulami, Ghosh, Pallavi · 2017 · Antimicrobial Agents and Chemotherapy

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Mycobacterium abscessus causes acute and chronic bronchopulmonary infection in patients with chronic lung damage, of which cystic fibrosis (CF) patients are particularly vulnerable. The major threat posed by this organism is its high intrinsic antibiotic resistance. A typical treatment regimen involves a 6- to 12-month-long combination therapy of clarithromycin and amikacin, with cure rates below 50% and multiple side effects, especially due to amikacin. In the present work, we show that M. abscessus whiB7 , a homologue of Mycobacterium tuberculosis and Mycobacterium smegmatis whiB7 with previously demonstrated effects on intrinsic antibiotic resistance, is strongly induced when exposed to clinically relevant antibiotics that target the ribosome: erythromycin, clarithromycin, amikacin, tetracycline, and spectinomycin. The deletion of M. abscessus whiB7 results in sensitivity to all of the above-mentioned antibiotics. Further, we have defined and compared the whiB7 regulon of M. abscessus with the closely related nontuberculous mycobacterium (NTM) M. smegmatis to demonstrate the induction of a species-specific repertoire of genes. Finally, we show that one such gene, eis2 , is specifically induced in M. abscessus by whiB7 and contributes to its higher levels of intrinsic amikacin resistance. This species-specific pattern of gene induction might account for the differences in drug susceptibilities to other antibiotics and between different mycobacterial species.

Overview

Integrity signals

Registry

Crossref · 10.1128/aac.01347-17

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 41 · Cited by 115

Metadata

Authors
Hurst-Hess, K., Rudra, P., & Ghosh, P.
Affiliations
New York State Department of Health (US)
Venue
Antimicrobial Agents and Chemotherapy
Published
2017-11
Volume
61
Issue
11
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2752023984
Cited by
115
References
41
Citations by year
2026: 14 · 2025: 11 · 2024: 16 · 2023: 12 · 2022: 15 · 2021: 16 · 2020: 10 · 2019: 13 · 2018: 7 · 2017: 1
FWCI
6.62
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
New York Community Trust (P16-000334)
Topics
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
Mycobacterium abscessus, intrinsic antibiotic resistance, ribosome-targeting antibiotics, amikacin resistance, clarithromycin, tetracycline, spectinomycin, erythromycin, Mycobacterium smegmatis, nontuberculous mycobacteria, cystic fibrosis, gene deletion
MeSH terms
Mycobacterium abscessus, Amikacin, Anti-Bacterial Agents, Bacterial Proteins, Microbial Sensitivity Tests, Mutation, Ribosomes, Gene Expression Regulation, Bacterial, Mycobacterium smegmatis, Drug Resistance, Multiple, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance. https://app.cochat.ai/papers/10.1128/aac.01347-17
The paper
Hurst-Hess, K., Rudra, P., & Ghosh, P. (2017). Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01347-17

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.